These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 8814419

  • 1. Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: results of a 6-month therapy study with coenzyme Q.
    Gold R, Seibel P, Reinelt G, Schindler R, Landwehr P, Beck A, Reichmann H.
    Eur Neurol; 1996; 36(4):191-6. PubMed ID: 8814419
    [Abstract] [Full Text] [Related]

  • 2. Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: a 31P NMR study.
    Nishikawa Y, Takahashi M, Yorifuji S, Nakamura Y, Ueno S, Tarui S, Kozuka T, Nishimura T.
    Neurology; 1989 Mar; 39(3):399-403. PubMed ID: 2538775
    [Abstract] [Full Text] [Related]

  • 3. Coenzyme Q10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy.
    Barbiroli B, Frassineti C, Martinelli P, Iotti S, Lodi R, Cortelli P, Montagna P.
    Cell Mol Biol (Noisy-le-grand); 1997 Jul; 43(5):741-9. PubMed ID: 9298596
    [Abstract] [Full Text] [Related]

  • 4. 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies.
    Bendahan D, Desnuelle C, Vanuxem D, Confort-Gouny S, Figarella-Branger D, Pellissier JF, Kozak-Ribbens G, Pouget J, Serratrice G, Cozzone PJ.
    Neurology; 1992 Jun; 42(6):1203-8. PubMed ID: 1603348
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study.
    Kornblum C, Schröder R, Müller K, Vorgerd M, Eggers J, Bogdanow M, Papassotiropoulos A, Fabian K, Klockgether T, Zange J.
    Eur J Neurol; 2005 Apr; 12(4):300-9. PubMed ID: 15804248
    [Abstract] [Full Text] [Related]

  • 9. Defective brain energy metabolism shown by in vivo 31P MR spectroscopy in 28 patients with mitochondrial cytopathies.
    Barbiroli B, Montagna P, Martinelli P, Lodi R, Iotti S, Cortelli P, Funicello R, Zaniol P.
    J Cereb Blood Flow Metab; 1993 May; 13(3):469-74. PubMed ID: 8478405
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Non-invasive investigation of muscle function using 31P magnetic resonance spectroscopy and 1H MR imaging].
    Bendahan D, Mattei JP, Guis S, Kozak-Ribbens G, Cozzone PJ.
    Rev Neurol (Paris); 2006 Apr; 162(4):467-84. PubMed ID: 16585908
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bio-energetic impairment in human calf muscle in thyroid disorders: a 31P MRS study.
    Khushu S, Rana P, Sekhri T, Sripathy G, Tripathi RP.
    Magn Reson Imaging; 2010 Jun; 28(5):683-9. PubMed ID: 20332062
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy.
    Chan A, Reichmann H, Kögel A, Beck A, Gold R.
    J Neurol; 1998 Oct; 245(10):681-5. PubMed ID: 9776469
    [Abstract] [Full Text] [Related]

  • 17. Changes in energy metabolism of calf muscle in patients with intermittent claudication assessed by 31P magnetic resonance spectroscopy: a phase II open study.
    Taylor DJ, Amato A, Hands LJ, Kemp GJ, Ramaswami G, Nicolaides A, Radda GK.
    Vasc Med; 1996 Oct; 1(4):241-5. PubMed ID: 9552578
    [Abstract] [Full Text] [Related]

  • 18. Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle.
    Pipinos II, Shepard AD, Anagnostopoulos PV, Katsamouris A, Boska MD.
    J Vasc Surg; 2000 May; 31(5):944-52. PubMed ID: 10805885
    [Abstract] [Full Text] [Related]

  • 19. High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy.
    Greiner A, Esterhammer R, Messner H, Biebl M, Mühlthaler H, Fraedrich G, Jaschke WR, Schocke MF.
    J Vasc Surg; 2006 May; 43(5):978-86. PubMed ID: 16678693
    [Abstract] [Full Text] [Related]

  • 20. [Phosphorus magnetic resonance in studying energy metabolism in skeletal muscles].
    Ternovoĭ SK, Veselova TN, Sinitsyn VE.
    Ross Fiziol Zh Im I M Sechenova; 2002 Mar; 88(3):348-55. PubMed ID: 12013729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.